GENEVA – Partnerships between industry, multilateral organizations, and other stakeholders are essential to overcoming challenges and improving access to innovations. This was the key message at an International Federation of Pharmaceutical Manufacturers (IFPMA) event on Tuesday evening, held on the sidelines of the World Health Assembly in Geneva. The gathering brought together representatives from the […] Continue reading ->
Senior WHO officials sounded a cautiously optimistic note Tuesday about the prospects for WHO member states to somehow wrap up down-to-the-wire negotiations on a landmark Pandemic Accord in time to submit a final agreement to the World Health Assembly, which begins next Monday, 27 May. Meanwhile, they heralded the milestone agreement “in principle” to amend […] Continue reading ->
WHO has expanded its list of trusted national regulatory authorities from three to 36 agencies – including the United States Food and Drug Adminstration (FDA), the European Medicines Agency (EMA) as well as the European Medicines Regulatory Network (EMRN), composed of the European Commission, and thirty national regulatory agencies. The WHO Listed Authorities (WLAs) are […] Continue reading ->
The World Health Organization (WHO) has updated its list of antibiotic-resistant bacteria that pose the greatest threat to human health, ranking the 15 families of bacteria that feature as “critical”, “high” and “medium” threats.  The Bacterial Priority Pathogens List (BPPL) 2024’s “critical” list features bacteria that are high burden, can resist treatment and spread resistance […] Continue reading ->
Researchers have developed a new all-in-one vaccine aimed at priming the body to respond to a range of different strains of coronaviruses, including the ones not yet known. The researchers from Cambridge, MIT and CalTech published their findings recently in Nature Nanotechnology. Their vaccine was successfully tested on mice and will likely enter human clinical trials […] Continue reading ->
Insulin pens are more affordable and preferred by diabetics but they are available almost exclusively in high-income countries due to gross overpricing, according to a report by Médecins Sans Frontières (MSF) and T1International, a British NGO fighting for equal treatment access for people with diabetes type 1. The research was presented on Wednesday, ahead of […] Continue reading ->
The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of […] Continue reading ->
Pharmacogenomics research in Africa transcends mere regional healthcare improvements: it represents a pivotal step in addressing pressing global health challenges and propelling medical science forward for all.  A revolution is sweeping through the field of medicine, redefining how we approach the treatment of diseases. Africa must not be left behind in this transformative journey. Pharmacogenomics, […] Continue reading ->